EXCLUSIVE LICENSE AGREEMENT between disc medicine, inc. and MABWELL THERAPEUTICS, INC. Entered into as of January 19, 2023Exclusive License Agreement • May 15th, 2023 • Disc Medicine, Inc. • Pharmaceutical preparations • New York
This Exclusive License Agreement (this “Agreement”) is made and entered into as of January 19, 2023 (the “Execution Date”) by and between Disc Medicine, Inc., a Delaware corporation having its registered address at 321 Arsenal Street, Suite 101, Watertown, MA 02472 (“Disc”), and Mabwell Therapeutics, Inc., a California corporation having its registered address at 505 Coast Boulevard South, Suite 301, La Jolla, CA 92037 (“Mabwell”). Disc and Mabwell are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
